CD276 and cancer: Given that B7-H3 protein was highly expressed on TCs and tumor-infiltrating blood vessels, while its expression level in normal human tissue was low, therapeutic strategies targeting B7-H3 may be able to achieve high therapeutic efficacy against cancer cells together with low toxicity in normal tissues (Seaman et al., 2007; Cheng et al., 2018).